# Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia

> **NCT04534127** · NA · RECRUITING · sponsor: **Alpha Tau Medical LTD.** · enrollment: 56 (estimated)

## Conditions studied

- Skin Cancer
- Mucosal Neoplasm of Oral Cavity
- Soft Tissue Neoplasm

## Interventions

- **DEVICE:** Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT)

## Key facts

- **NCT ID:** NCT04534127
- **Lead sponsor:** Alpha Tau Medical LTD.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-12-22
- **Primary completion:** 2026-01-01
- **Final completion:** 2026-01-01
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2025-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04534127

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04534127, "Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04534127. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*